Skip to main content
Erschienen in: Breast Cancer Research and Treatment 1/2007

01.05.2007 | Review

Magnetic resonance imaging of breast lesions—a pathologic correlation

verfasst von: Gary M. K. Tse, Benjaporn Chaiwun, Ka-Tak Wong, David K. Yeung, Amy L. M. Pang, Alice P. Y. Tang, Humairah S. Cheung

Erschienen in: Breast Cancer Research and Treatment | Ausgabe 1/2007

Einloggen, um Zugang zu erhalten

Abstract

Magnetic resonance imaging of the breast is useful in assessing breast lesions. An understanding of the pathologic characteristics of the tumors may help to understand these magnetic resonance imaging observations.
Large lesional size (>10 mm), ill-defined margin, and irregular outlines are associated with malignancy. These correlate with the pathological features of breast tumor, characterized by rapid growth rate, large size, and infiltrative growth pattern, invasion into stroma resulting in desmoplasia, and hence irregular outline and margin. The detection and estimation of tumor extent of invasive lobular carcinoma is problematic, even with magnetic resonance imaging, which is considered the most sensitivity. This inaccuracy likely derives from the characteristic linear, single cells infiltration growth pattern of the tumor, which is also often underestimated by clinical examination. Estimation of tumor extent after neoadjuvant chemotherapy is also essential but problematic by imaging, as the shrunken tumor becomes fibrotic, with stromal hyalinization, diminished microvasculature and tumor break up causing size underestimation. Non-enhancement of breast tumors occurs in about 8% of cases correlates with diffuse growth pattern, particularly of infiltrative lobular carcinoma. The observation of disproportionately high non-enhancing ductal carcinoma in situ remains an enigma. Finally, early rim enhancement correlates with small cancer nests, low ratio of peripheral to central fibrosis and high ratio of peripheral to central microvessel density. These may be related to increased vascular endothelial growth factor mediated increased microvessel density as well as increased permeability, which manifest as increased rapid contrast uptake and dissipation.
Literatur
1.
Zurück zum Zitat Heywang SH, Hahn D, Schmidt H et al (1986) MRI imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199–204PubMedCrossRef Heywang SH, Hahn D, Schmidt H et al (1986) MRI imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr 10:199–204PubMedCrossRef
2.
Zurück zum Zitat Bone B, Pentek Z, Perbeck L et al (1997) Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 38:489–496PubMed Bone B, Pentek Z, Perbeck L et al (1997) Diagnostic accuracy of mammography and contrast-enhanced MR imaging in 238 histologically verified breast lesions. Acta Radiol 38:489–496PubMed
3.
Zurück zum Zitat Stomper PC, Winston JS, Herman S et al (1997) Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 45:39–46PubMedCrossRef Stomper PC, Winston JS, Herman S et al (1997) Angiogenesis and dynamic MR imaging gadolinium enhancement of malignant and benign breast lesions. Breast Cancer Res Treat 45:39–46PubMedCrossRef
4.
Zurück zum Zitat Boetes C, Barentsz JO, Mus RD et al (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 193:777–781PubMed Boetes C, Barentsz JO, Mus RD et al (1994) MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 193:777–781PubMed
5.
Zurück zum Zitat Heiberg EV, Perman WH, Herrmann VM et al (1996) Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging 14:337–348PubMedCrossRef Heiberg EV, Perman WH, Herrmann VM et al (1996) Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging 14:337–348PubMedCrossRef
6.
Zurück zum Zitat Muller-Schimpfle M, Stoll P, Stern W et al (1997) Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography? AJR Am J Roentgenol 168:1323–1329PubMed Muller-Schimpfle M, Stoll P, Stern W et al (1997) Do mammography, sonography, and MR mammography have a diagnostic benefit compared with mammography and sonography? AJR Am J Roentgenol 168:1323–1329PubMed
7.
Zurück zum Zitat Heywang-Kobrunner SH, Viehweg P, Heinig A et al (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94–108PubMedCrossRef Heywang-Kobrunner SH, Viehweg P, Heinig A et al (1997) Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 24:94–108PubMedCrossRef
8.
Zurück zum Zitat Morris EA, Schwartz LH, Dershaw DD et al (1997) MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205:437–440PubMed Morris EA, Schwartz LH, Dershaw DD et al (1997) MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 205:437–440PubMed
9.
Zurück zum Zitat Boetes C, Mus RD, Holland R et al (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743–747PubMed Boetes C, Mus RD, Holland R et al (1995) Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 197:743–747PubMed
10.
Zurück zum Zitat Kepple J, Layeeque R, Klimberg VS et al (2005) Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190:623–627PubMedCrossRef Kepple J, Layeeque R, Klimberg VS et al (2005) Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190:623–627PubMedCrossRef
11.
Zurück zum Zitat Rieber A, Merkle E, Bohm W et al (1997) MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21:773–779PubMedCrossRef Rieber A, Merkle E, Bohm W et al (1997) MRI of histologically confirmed mammary carcinoma: clinical relevance of diagnostic procedures for detection of multifocal or contralateral secondary carcinoma. J Comput Assist Tomogr 21:773–779PubMedCrossRef
12.
Zurück zum Zitat Orel SG, Schnall MD, Powell CM et al (1995) Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196:115–122PubMed Orel SG, Schnall MD, Powell CM et al (1995) Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 196:115–122PubMed
13.
Zurück zum Zitat Mumtaz H, Hall-Craggs MA, Davidson T et al (1997) Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169:417–424PubMed Mumtaz H, Hall-Craggs MA, Davidson T et al (1997) Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 169:417–424PubMed
14.
Zurück zum Zitat Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881–888PubMed Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213:881–888PubMed
15.
Zurück zum Zitat Muuller RD, Barkhausen J, Sauerwein W et al (1998) Assessment of local recurrence after breast-conserving therapy with MRI. J Comput Assist Tomogr 22:408–412PubMedCrossRef Muuller RD, Barkhausen J, Sauerwein W et al (1998) Assessment of local recurrence after breast-conserving therapy with MRI. J Comput Assist Tomogr 22:408–412PubMedCrossRef
16.
Zurück zum Zitat Liberman L, Morris EA, Lee MJ et al (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179:171–178PubMed Liberman L, Morris EA, Lee MJ et al (2002) Breast lesions detected on MR imaging: features and positive predictive value. AJR Am J Roentgenol 179:171–178PubMed
17.
Zurück zum Zitat Siegmann KC, Muller-Schimpfle M, Schick F et al (2002) MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol 178:1403–1409PubMed Siegmann KC, Muller-Schimpfle M, Schick F et al (2002) MR imaging-detected breast lesions: histopathologic correlation of lesion characteristics and signal intensity data. AJR Am J Roentgenol 178:1403–1409PubMed
18.
Zurück zum Zitat Elston C, Ellis IO (2000) Assessment of histological grade. In: Elston CW, Ellis IO (eds), Symmets W (Emeritus Editor) The breast, systemic pathology, Col 13. Churchill Livingston, Edinburgh, pp 365–384 Elston C, Ellis IO (2000) Assessment of histological grade. In: Elston CW, Ellis IO (eds), Symmets W (Emeritus Editor) The breast, systemic pathology, Col 13. Churchill Livingston, Edinburgh, pp 365–384
19.
Zurück zum Zitat Walker RA, Camplejohn RS (1986) DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 150:37–42PubMedCrossRef Walker RA, Camplejohn RS (1986) DNA flow cytometry of human breast carcinomas and its relationship to transferrin and epidermal growth factor receptors. J Pathol 150:37–42PubMedCrossRef
20.
Zurück zum Zitat Bouzubar N, Walker KJ, Griffiths K et al (1989) Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59:943–947PubMed Bouzubar N, Walker KJ, Griffiths K et al (1989) Ki67 immunostaining in primary breast cancer: pathological and clinical associations. Br J Cancer 59:943–947PubMed
21.
Zurück zum Zitat Fechner RE (1987) Fibroadenoma and related lesions. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 72–85 Fechner RE (1987) Fibroadenoma and related lesions. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 72–85
22.
Zurück zum Zitat Tsang WY, Chan JK et al (1996) Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 20:921–943PubMedCrossRef Tsang WY, Chan JK et al (1996) Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics. Am J Surg Pathol 20:921–943PubMedCrossRef
23.
Zurück zum Zitat Tse GM, Ma TK, Chu WC et al (2004) Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters. Mod Pathol 17:568–572PubMedCrossRef Tse GM, Ma TK, Chu WC et al (2004) Neuroendocrine differentiation in pure type mammary mucinous carcinoma is associated with favorable histologic and immunohistochemical parameters. Mod Pathol 17:568–572PubMedCrossRef
24.
Zurück zum Zitat Nassar H, Qureshi H, Volkanadsay N et al (2006) Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30:501–507PubMedCrossRef Nassar H, Qureshi H, Volkanadsay N et al (2006) Clinicopathologic analysis of solid papillary carcinoma of the breast and associated invasive carcinomas. Am J Surg Pathol 30:501–507PubMedCrossRef
25.
Zurück zum Zitat Orel SG, Schnall MD, LiVolsi VA et al (1994) Suspicious breast lesions: MR imaging with radiologic–pathologic correlation. Radiology 190:485–493PubMed Orel SG, Schnall MD, LiVolsi VA et al (1994) Suspicious breast lesions: MR imaging with radiologic–pathologic correlation. Radiology 190:485–493PubMed
26.
Zurück zum Zitat Weinreb JC, Newstead G (1995) MR imaging of the breast. Radiology 196:593–610PubMed Weinreb JC, Newstead G (1995) MR imaging of the breast. Radiology 196:593–610PubMed
27.
Zurück zum Zitat Krecke KN, Gisvold JJ (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 161:957–960PubMed Krecke KN, Gisvold JJ (1993) Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol 161:957–960PubMed
28.
Zurück zum Zitat Davis PL, Staiger MJ, Harris KB et al (1996) Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat 37:1–9PubMedCrossRef Davis PL, Staiger MJ, Harris KB et al (1996) Breast cancer measurements with magnetic resonance imaging, ultrasonography, and mammography. Breast Cancer Res Treat 37:1–9PubMedCrossRef
29.
Zurück zum Zitat Paramagul CP, Helvie MA, Adler DD (1995) Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology 195:231–234PubMed Paramagul CP, Helvie MA, Adler DD (1995) Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology 195:231–234PubMed
30.
Zurück zum Zitat Butler RS, Venta LA, Wiley EL et al (1999) Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol 172:325–330PubMed Butler RS, Venta LA, Wiley EL et al (1999) Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol 172:325–330PubMed
31.
Zurück zum Zitat Kepple J, Layeeque R, Klimberg VS et al (2005) Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190:623–627PubMedCrossRef Kepple J, Layeeque R, Klimberg VS et al (2005) Correlation of magnetic resonance imaging and pathologic size of infiltrating lobular carcinoma of the breast. Am J Surg 190:623–627PubMedCrossRef
32.
Zurück zum Zitat Boetes C, Veltman J, van Die L et al (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86:31–37PubMedCrossRef Boetes C, Veltman J, van Die L et al (2004) The role of MRI in invasive lobular carcinoma. Breast Cancer Res Treat 86:31–37PubMedCrossRef
33.
Zurück zum Zitat AJCC (2002) Cancer staging handbook, 6th edn. Springer, New York, pp 255–282 AJCC (2002) Cancer staging handbook, 6th edn. Springer, New York, pp 255–282
34.
Zurück zum Zitat Qayyum A, Birdwell RL, Daniel BL et al (2002) MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 178:1227–1232PubMed Qayyum A, Birdwell RL, Daniel BL et al (2002) MR imaging features of infiltrating lobular carcinoma of the breast: histopathologic correlation. AJR Am J Roentgenol 178:1227–1232PubMed
35.
Zurück zum Zitat Page DL, Anderson TJ, Sakamoto G (1987) Infiltrating carcinoma: major histological types. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 193–235 Page DL, Anderson TJ, Sakamoto G (1987) Infiltrating carcinoma: major histological types. In: Page DL, Anderson TJ (eds) Diagnostic histopathology of the breast. Churchill Livingstone, Edinburgh, pp 193–235
36.
Zurück zum Zitat Bonadonna G, Veronesi U, Brambilla C et al (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539–1545PubMedCrossRef Bonadonna G, Veronesi U, Brambilla C et al (1990) Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 82:1539–1545PubMedCrossRef
37.
Zurück zum Zitat Calais G, Berger C, Descamps P et al (1994) Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74:1283–1288PubMedCrossRef Calais G, Berger C, Descamps P et al (1994) Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm. Cancer 74:1283–1288PubMedCrossRef
38.
Zurück zum Zitat Cocconi G, Di Blasio B, Alberti G et al (1984) Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 4:309–313PubMedCrossRef Cocconi G, Di Blasio B, Alberti G et al (1984) Problems in evaluating response of primary breast cancer to systemic therapy. Breast Cancer Res Treat 4:309–313PubMedCrossRef
39.
Zurück zum Zitat Segel MC, Paulus DD, Hortobagyi GN (1988) Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 169:49–54PubMed Segel MC, Paulus DD, Hortobagyi GN (1988) Advanced primary breast cancer: assessment at mammography of response to induction chemotherapy. Radiology 169:49–54PubMed
40.
Zurück zum Zitat Partridge SC, Gibbs JE, Lu Y et al (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193–1199PubMed Partridge SC, Gibbs JE, Lu Y et al (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 179:1193–1199PubMed
41.
Zurück zum Zitat Esserman L, Kaplan E, Partridge S et al (2001) MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 8:549–559PubMedCrossRef Esserman L, Kaplan E, Partridge S et al (2001) MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer. Ann Surg Oncol 8:549–559PubMedCrossRef
42.
Zurück zum Zitat Delille JP, Slanetz PJ, Yeh ED et al (2003) Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 228:63–69 (Epub 2003 May 29)PubMedCrossRef Delille JP, Slanetz PJ, Yeh ED et al (2003) Invasive ductal breast carcinoma response to neoadjuvant chemotherapy: noninvasive monitoring with functional MR imaging pilot study. Radiology 228:63–69 (Epub 2003 May 29)PubMedCrossRef
43.
Zurück zum Zitat Yeh E, Slanetz P, Kopans DB, Rafferty E et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868–877PubMed Yeh E, Slanetz P, Kopans DB, Rafferty E et al (2005) Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 184:868–877PubMed
44.
Zurück zum Zitat Dao TH, Rahmouni A, Campana F (1993) Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187:751–755PubMed Dao TH, Rahmouni A, Campana F (1993) Tumor recurrence versus fibrosis in the irradiated breast: differentiation with dynamic gadolinium-enhanced MR imaging. Radiology 187:751–755PubMed
45.
Zurück zum Zitat Wasser K, Sinn HP, Fink C et al (2003) Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 13:1213–1223 (Epub 2002 Nov 30)PubMed Wasser K, Sinn HP, Fink C et al (2003) Accuracy of tumor size measurement in breast cancer using MRI is influenced by histological regression induced by neoadjuvant chemotherapy. Eur Radiol 13:1213–1223 (Epub 2002 Nov 30)PubMed
46.
Zurück zum Zitat Elston CW, Ellis IO, Pinder SE (2000) Effects of treatment. In: Elston CW, Ellis IO (eds), Symmets W (Emeritus Editor) The breast, systemic pathology, Col 13. Churchill Livingston, Edinburgh, pp 463–476 Elston CW, Ellis IO, Pinder SE (2000) Effects of treatment. In: Elston CW, Ellis IO (eds), Symmets W (Emeritus Editor) The breast, systemic pathology, Col 13. Churchill Livingston, Edinburgh, pp 463–476
47.
Zurück zum Zitat Knopp MV, Brix G, Junkermann HJ et al (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 2:633–658PubMed Knopp MV, Brix G, Junkermann HJ et al (1994) MR mammography with pharmacokinetic mapping for monitoring of breast cancer treatment during neoadjuvant therapy. Magn Reson Imaging Clin N Am 2:633–658PubMed
48.
Zurück zum Zitat Harms SE, Flamig DP, Hesley KL et al (1993) Fat-suppressed three-dimensional MR imaging of the breast. Radiographics 13:247–267PubMed Harms SE, Flamig DP, Hesley KL et al (1993) Fat-suppressed three-dimensional MR imaging of the breast. Radiographics 13:247–267PubMed
49.
Zurück zum Zitat Bone B, Aspelin P, Bronge L et al (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37:208–213PubMedCrossRef Bone B, Aspelin P, Bronge L et al (1996) Sensitivity and specificity of MR mammography with histopathological correlation in 250 breasts. Acta Radiol 37:208–213PubMedCrossRef
50.
Zurück zum Zitat Gilles R, Guinebretiere JM, Lucidarme O et al (1994) Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191:625–631PubMed Gilles R, Guinebretiere JM, Lucidarme O et al (1994) Nonpalpable breast tumors: diagnosis with contrast-enhanced subtraction dynamic MR imaging. Radiology 191:625–631PubMed
51.
Zurück zum Zitat Boetes C, Strijk SP, Holland R et al (1997) False-negative MR imaging of malignant breast tumors. Eur Radiol 7:1231–1234PubMedCrossRef Boetes C, Strijk SP, Holland R et al (1997) False-negative MR imaging of malignant breast tumors. Eur Radiol 7:1231–1234PubMedCrossRef
52.
Zurück zum Zitat Teifke A, Hlawatsch A, Beier T, Werner Vomweg T, Schadmand S et al (2002) Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 224:881–888PubMedCrossRef Teifke A, Hlawatsch A, Beier T, Werner Vomweg T, Schadmand S et al (2002) Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0 T. Radiology 224:881–888PubMedCrossRef
53.
Zurück zum Zitat Ghai S, Muradali D, Bukhanov K et al (2005) Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. AJR Am J Roentgenol 185:481–487PubMed Ghai S, Muradali D, Bukhanov K et al (2005) Nonenhancing breast malignancies on MRI: sonographic and pathologic correlation. AJR Am J Roentgenol 185:481–487PubMed
54.
Zurück zum Zitat Hansen S, Grabau DA, Sorensen FB et al (2006) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6:139–146 Hansen S, Grabau DA, Sorensen FB et al (2006) The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients. Clin Cancer Res 6:139–146
55.
Zurück zum Zitat Chhieng DC, Tabbara SO, Marley EF et al (2003) Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. Breast J 9:200–207PubMedCrossRef Chhieng DC, Tabbara SO, Marley EF et al (2003) Microvessel density and vascular endothelial growth factor expression in infiltrating lobular mammary carcinoma. Breast J 9:200–207PubMedCrossRef
56.
Zurück zum Zitat Morphopoulos G, Pearson M, Ryder WD et al (1996) Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol 180:44–49PubMedCrossRef Morphopoulos G, Pearson M, Ryder WD et al (1996) Tumour angiogenesis as a prognostic marker in infiltrating lobular carcinoma of the breast. J Pathol 180:44–49PubMedCrossRef
57.
Zurück zum Zitat Komatsu S, Lee CJ, Hosokawa Y, Ichikawa D et al (2004) Comparison of intraductal spread on dynamic contrast-enhanced MRI with clinicopathologic features in breast cancer. Jpn J Clin Oncol 34:515–518PubMedCrossRef Komatsu S, Lee CJ, Hosokawa Y, Ichikawa D et al (2004) Comparison of intraductal spread on dynamic contrast-enhanced MRI with clinicopathologic features in breast cancer. Jpn J Clin Oncol 34:515–518PubMedCrossRef
58.
Zurück zum Zitat Ikeda O, Nishimura R, Miyayama H et al (2004) Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer. Acta Radiol 45:721–725PubMedCrossRef Ikeda O, Nishimura R, Miyayama H et al (2004) Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer. Acta Radiol 45:721–725PubMedCrossRef
59.
Zurück zum Zitat Cao Y, Paner GP, Kahn LB et al (2004) Noninvasive carcinoma of the breast: angiogenesis and cell proliferation. Arch Pathol Lab Med 128:893–896PubMed Cao Y, Paner GP, Kahn LB et al (2004) Noninvasive carcinoma of the breast: angiogenesis and cell proliferation. Arch Pathol Lab Med 128:893–896PubMed
60.
Zurück zum Zitat Ruiz A, Almenar S, Cerda M et al (2002) Ductal carcinoma in situ of the breast: a comparative analysis of histology, nuclear area, ploidy, and neovascularization provides differentiation between low- and high-grade tumors. Breast J 8:139–144PubMedCrossRef Ruiz A, Almenar S, Cerda M et al (2002) Ductal carcinoma in situ of the breast: a comparative analysis of histology, nuclear area, ploidy, and neovascularization provides differentiation between low- and high-grade tumors. Breast J 8:139–144PubMedCrossRef
61.
Zurück zum Zitat Guidi AJ, Schnitt SJ, Fischer L et al (1997) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 80:1945–1953PubMedCrossRef Guidi AJ, Schnitt SJ, Fischer L et al (1997) Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast. Cancer 80:1945–1953PubMedCrossRef
62.
Zurück zum Zitat Weinreb JC, Newstead (1995) G.MR imaging of the breast. Radiology 196:593–610PubMed Weinreb JC, Newstead (1995) G.MR imaging of the breast. Radiology 196:593–610PubMed
63.
Zurück zum Zitat Rubens D, Totterman S, Chacko AK et al (1991) Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast. AJR Am J Roentgenol 157:267–270PubMed Rubens D, Totterman S, Chacko AK et al (1991) Gadopentetate dimeglumine-enhanced chemical-shift MR imaging of the breast. AJR Am J Roentgenol 157:267–270PubMed
64.
Zurück zum Zitat Kerslake RW, Carleton PJ, Fox JN et al (1995) Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast. Clin Radiol 50:440–454PubMedCrossRef Kerslake RW, Carleton PJ, Fox JN et al (1995) Dynamic gradient-echo and fat-suppressed spin-echo contrast-enhanced MRI of the breast. Clin Radiol 50:440–454PubMedCrossRef
65.
Zurück zum Zitat Kuhl CK, Mielcareck P, Klaschik S et al (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101–110PubMed Kuhl CK, Mielcareck P, Klaschik S et al (1999) Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 211:101–110PubMed
66.
Zurück zum Zitat Matsubayashi R, Matsuo Y, Edakuni G et al (2000) Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 217:841–848PubMed Matsubayashi R, Matsuo Y, Edakuni G et al (2000) Breast masses with peripheral rim enhancement on dynamic contrast-enhanced MR images: correlation of MR findings with histologic features and expression of growth factors. Radiology 217:841–848PubMed
67.
Zurück zum Zitat Ahlgren J, Risberg B, Villman K et al (2002) Angiogenesis in invasive breast carcinoma – a prospective study of tumour heterogeneity. Eur J Cancer 38:64–69PubMedCrossRef Ahlgren J, Risberg B, Villman K et al (2002) Angiogenesis in invasive breast carcinoma – a prospective study of tumour heterogeneity. Eur J Cancer 38:64–69PubMedCrossRef
68.
Zurück zum Zitat Kato T, Kameoka S, Kimura T et al (2001) Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 70:65–74PubMedCrossRef Kato T, Kameoka S, Kimura T et al (2001) Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 70:65–74PubMedCrossRef
69.
Zurück zum Zitat Santinelli A, Baccarini M, Colanzi P et al (2000) Microvessel quantitation in intraductal and early invasive breast carcinomas. Anal Quant Cytol Histol 22:277–284PubMed Santinelli A, Baccarini M, Colanzi P et al (2000) Microvessel quantitation in intraductal and early invasive breast carcinomas. Anal Quant Cytol Histol 22:277–284PubMed
Metadaten
Titel
Magnetic resonance imaging of breast lesions—a pathologic correlation
verfasst von
Gary M. K. Tse
Benjaporn Chaiwun
Ka-Tak Wong
David K. Yeung
Amy L. M. Pang
Alice P. Y. Tang
Humairah S. Cheung
Publikationsdatum
01.05.2007
Erschienen in
Breast Cancer Research and Treatment / Ausgabe 1/2007
Print ISSN: 0167-6806
Elektronische ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9352-3

Weitere Artikel der Ausgabe 1/2007

Breast Cancer Research and Treatment 1/2007 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.